Comparison of Clomiphene Citrate and Gonadotropins in Ovulation Induction Cycles
Information source: Universitair Ziekenhuis Brussel
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Infertility
Intervention: clomiphene citrate (Drug); gonadotropins (Drug)
Phase: Phase 4
Status: Recruiting
Sponsored by: Universitair Ziekenhuis Brussel Overall contact:
Christophe blockeel, Phone: +3224776699, Email: cblockee@uzbrussel.be
Summary
The purpose of the present study is to analyse prospectively if highly purified hMG compared
with increased dose of clomiphene citrate has different outcomes in folliculogenesis in
ovulation induction cycles.
Clinical Details
Official title: Among Non-IVF Patients Undergoing Ovulation Induction With Clomiphene Citrate (Clomid® 50 mg), Does Administration of an Increased Dose of Clomiphene Citrate (Clomid® 100 mg) Compared With Gonadotropins, Achieve Similar Rates of Folliculogenesis?
Study design: Treatment, Randomized, Single Blind (Subject), Active Control, Parallel Assignment, Efficacy Study
Primary outcome: folliculogenesis
Secondary outcome: pregnancy rate
Eligibility
Minimum age: 18 Years.
Maximum age: 38 Years.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- < 39 years old on day of randomisation
- FSH < 12 (in the early follicular phase)
- Normal ultrasound scan, i. e. presence of both ovaries, without evidence of
abnormality within 6 months prior to randomisation.
- Chronic oligo or anovulation (WHO 2)
- BMI between 18 and 31 (both inclusive)
Exclusion Criteria:
- ≥ 39 years old on day of randomisation
Locations and Contacts
Christophe blockeel, Phone: +3224776699, Email: cblockee@uzbrussel.be
UZ Brussel, Jette 1090, Belgium; Recruiting
christophe blockeel, MD, Phone: +3224776699, Email: cblockee@uzbrussel.be
Additional Information
Starting date: August 2008
Ending date: April 2009
Last updated: February 3, 2009
|
